Close

VIVO Financial Facts

INCOME TAX PROVISION: 3.26M
COST OF SALES: 17.28M
See Full Income Statement

Inventories: 45.06M
Other accrued expenses: -6.23M
See Full Balance Sheet

Meridian Bioscience Inc. (VIVO) Earnings

  |   Expand Research on VIVO
Next EPS Date N/A EPS Growth Rate -100.0% *Last Qtr.
Average EPS % Beat Rate +39.6% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +5.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/14/22 Q422 N/A$0.12 N/A N/A$63M = N/A N/A
11/10/22 Q422 N/A$0.20 N/A N/A$71.95M = N/A N/A
1/26/23 Q123 N/A$0.20 N/A N/A$72.3M N/A N/A N/A
2/7/20 Q120 $0.10$0.06 +$0.04$47.4M$48.7M = Details
11/9/17 Q417 $0.13$0.15 -$0.02$49M$48.05M = Details
11/7/19 Q419 $0.13$0.09 +$0.04$50.8M$50.59M = Details
11/10/16 Q416 $0.14$0.14 $0.00$47M$47.7M = Details
1/25/18 Q118 $0.15$0.15 $0.00$52.3M$49M = Details